SkinBioTherapeutics Revenue

Biotechnology Research • Newcastle upon Tyne, England, United Kingdom • 1-10 Employees

SkinBioTherapeutics revenue & valuation

Annual revenue	$1,209,000
Revenue per employee	$121,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,900,000
Total funding	$5,200,000

Key Contacts at SkinBioTherapeutics

Stuart J. Ashman

Chief Executive Officer

Emily Bertram

Group Finance Director

Company overview

Headquarters	The Core, Science Central, Bath Lane, Newcastle upon Tyne, NE4 5TF, GB
Phone number	+441914957325
Website	skinbiotherapeutics.com
SIC	283
Keywords	Skincare
Founded	2015
Employees	1-10
Socials

About SkinBioTherapeutics

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CEO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester. The SkinBioTherapeutics platform applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to the skin. The Company has shown that the SkinBiotix® platform can improve the barrier effect of skin models, improve repair and reduce bacterial load. SkinBioTherapeutics is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema. In each of these areas, SkinBioTherapeutics plans to exemplify its technology in human studies. The most advanced programme is focused on the application of the SkinBiotix® platform in managing sensitive skin in the cosmetics industry. The business strategy is to partner and out-license its programmes at the proof of concept. SkinBioTherapeutics plc was admitted to London's AIM on 5th April 2017, raising £4.5m.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Manager

C-Suite

Director

Employees by Department

SkinBioTherapeutics has 7 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore SkinBioTherapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-01-15	14	$3,200,000
2024-09-02	14	$2,000,000

Funding Insights

$5,200,000

Total funding amount

$2,000,000

Most recent funding amount

Number of funding rounds

SkinBioTherapeutics Tech Stack

Discover the technologies and tools that power SkinBioTherapeutics's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

SiteGround

Hosting

Animate.css

UI frameworks

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Yoast SEO

SEO

Cookie Notice

Cookie compliance

Google Tag Manager

Tag managers

Frequently asked questions

SkinBioTherapeutics is located in Newcastle upon Tyne, England, GB.

You can reach SkinBioTherapeutics at +441914957325.

SkinBioTherapeutics generates an estimated annual revenue of $1,209,000. This revenue figure reflects the company's market position and business performance in its industry.

SkinBioTherapeutics has an estimated valuation of $3,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

SkinBioTherapeutics was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

SkinBioTherapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

SkinBioTherapeutics has raised a total of $5,200,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at SkinBioTherapeutics

Stuart J. Ashman

Chief Executive Officer

Emily Bertram

Group Finance Director

4.8

40,000 users